E5 monoclonal antibody: XOMA and partner Pfizer (New York, N.Y.) halted their third Phase III trial for sepsis after an interim review by an institutional revie

(IND withdrawn temporarily, see Clinical Status.)

Xoma Corp. (XOMA), Berkeley,

Read the full 104 word article

How to gain access

Continue reading with a
two-week free trial.